MLS Weekly Preview: Congress Keeping its Focus on Drug Costs

By Alexander Hecht

This week, Congress will continue to look at lowering health costs. The House has been focused on both drug costs and overall health care costs, advancing packages to strengthen the individual market in addition to a series of bipartisan drug pricing bills. We cover this and more in this week's preview, which you can find by clicking here. 

Subscribe To Viewpoints

Published

    • Viewpoint Topics

  • Health Care
  • ML Strategies
  • Health Care Compliance, Fraud and Abuse, & Regulatory Counseling

    • Professionals

  • Alexander Hecht

    • Related Practices

  • Health Care Compliance, Fraud & Abuse, and Regulatory Counseling
  • Lobbying & Public Policy

    • Related Industries

  • PBMs & Pharmacies

    • Author

    Alexander Hecht

    ML Strategies - Executive Vice President & Director of Operations

    Alexander Hecht is Executive Vice President & Director of Operations of ML Strategies, Washington, DC. He's an attorney with over a decade of senior-level experience in Congress and trade associations. Alex helps clients with regulatory and legislative issues, including health care and technology.